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Abstract
Fibronectin (FN) is a major component of the tumor microenvironment, but its role in promoting 
metastasis is incompletely understood. Here we show that FN gradients elicit directional 
movement of breast cancer cells, in vitro and in vivo. Haptotaxis on FN gradients requires direct 
interaction between α5β1 integrin and Mena, an actin regulator, and involves increases in focal 
complex signaling and tumor-cell-mediated extracellular matrix (ECM) remodeling. Compared to 
Mena, higher levels of the pro-metastatic MenaINV isoform associate with α5, which enables 3D 
haptotaxis of tumor cells towards the high FN concentrations typically present in perivascular 
space and in the periphery of breast tumor tissue. MenaINV and FN levels were correlated in two 
breast cancer cohorts, and high levels of MenaINV were significantly associated with increased 
tumor recurrence as well as decreased patient survival. Our results identify a novel tumor-cell-
intrinsic mechanism that promotes metastasis through ECM remodeling and ECM guided 
directional migration.
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Introduction
The tissue microenvironment is composed of stromal cells and extracellular matrix (ECM) 
and is known to contribute to tumor progression(1). This compartment is rich in substrate-
bound and soluble cues, and provides both the structure and signals that promote tumor cell 
proliferation, survival and invasion(2). The most abundant ECM proteins in mouse 
metastatic breast tumors are fibronectin (FN) and collagens(3). In breast cancer patients, 
collagen organization has high prognostic value(4,5) and increased FN correlates with 
disease progression and mortality(6,7). The context and mechanisms by which tumor cells 
sense and respond to changes in ECM abundance and architecture during invasion and 
metastasis, however, remain poorly understood.
Cancer cells can respond to a variety of cues in order to locally invade and metastasize. 
Growth factor-mediated chemotaxis is known to be important for local invasion and 
metastasis(8). Far less is known about haptotaxis, a process in which cell migration is guided 
by gradients of surface-bound molecules such as ECM. This is particularly relevant to 
cancer, where the amount of FN within tumors can vary greatly, with high concentrations of 
FN typically found near blood vessels, tumor periphery and in metastatic sites(9,10). While 
FN can activate intracellular signaling pathways via integrins(11), the predominant class of 
surface adhesion receptors, cells can also remodel the ECM, for example, by driving 
integrin-mediated assembly of soluble FN into fibrils(12). FN is also known to play an 
important role in collagen fibrillogenesis(13). Bidirectional communication between cells 
and ECM cues regulates cell behavior as well as the composition and structure of the 
surrounding ECM.
Mena, a member of the Ena/VASP family of actin filament elongation factors, is upregulated 
in various cancers and undergoes alternative splicing during breast cancer progression(14). 
Mena binds to the C-terminal end of the cytoplasmic tail of the integrin α5 via an LERER 
repeat domain absent from other Ena/VASP proteins(15). In fibroblasts, Mena regulates both 
outside-in and inside-out signaling at focal complexes via its interaction with α5 (15). 
MenaINV, an alternatively spliced isoform containing a 19-amino acid inclusion (encoded by 
the “INV” exon), is expressed in aggressive tumor cell subpopulations(16). MenaINV 
expression promotes metastasis by increasing sensitivity to EGF(17) and the efficiency of 
matrix degradation, invasion and intravasation (18). Together, these findings led us to 
hypothesize that the ECM may also play an important role in Mena/MenaINV-driven 
metastasis. Using pre-clinical models and analysis of patient samples, we describe a 
previously unappreciated mechanism of metastasis, where upregulation of Mena and its 
invasive isoform endows tumor cells with the ability to migrate up FN gradients and fashion 
their own pathway towards the bloodstream.
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Results
Mena drives haptotaxis of tumor cells on FN gradients via its interactions with α5β1 and F-
actin
Based on the recent finding that Mena interacts with the cytoplasmic tail of one of the main 
FN receptors α5, we hypothesized that Mena may be involved in directional migration 
responses to gradients of FN. Using a recently developed microfluidic device, we studied 
cells migrating on FN gradients by time-lapse imaging, and quantified their forward 
migration index (FMI) to assess haptotaxis (Fig1A) (19,20). First, MVD7 fibroblasts, which 
lack all three Ena/VASP proteins (Mena, VASP and EVL(21)) migrated actively in the 
device, however, they failed to haptotax on the FN gradient. Interestingly, Mena-, but not 
VASP-, EVL- expressing MVD7 cells exhibited a robust haptotactic response and migrated 
up the FN gradient (Fig1B), even though expression of each of the three Ena/VASP proteins 
had previously reported, similar effects on cell speed (21) (FigS1A).
We next examined Mena-dependent effects on haptotaxis of breast cancer cells. In serum-
free conditions, MDAMB231 cells become enriched on the FN coated undersides of porous 
filters in transwell assays(22), however, we found that this cell type failed to exhibit 
directional movement on FN gradients (Fig1C). MDAMB231 cell lines stably expressing 
GFP-tagged Mena or control-GFP construct at levels similar to those seen in invading cells 
in vivo were generated (referred to as 231-Control or Mena) (23)(FigS1B,C). Ectopic 
expression of Mena enabled significant haptotactic responses on 2D gradients of FN, but not 
of on 2D laminin (LN) or vitronectin (VN) gradients (Fig1C), without affecting cell speed 
(FigS1D). Varying the concentration of either VN or LN affected the speed of MDAMB231 
and 231-Mena cells, but failed to elicit significant haptotactic responses at any concentration 
tested (FigS1D-G).
In 3D collagen gels with FN gradients, Mena expression also induced a strong haptotactic 
response (Fig1D), independently of velocity (FigS1E). While the exact concentration of FN 
in tumors is unknown, FN is expressed by tumor and stromal cells, and accumulates in the 
perivascular area via leakage from the bloodstream, where FN levels as high as 400μg/ml 
have been observed(24). Due to the heterogeneous levels of FN found in tumors, we studied 
haptotaxis 3D collagen gels in response to gradients generated from different source 
concentrations of FN. In high levels of FN (up to 500μg/ml), 231-GFP and 231-Mena cells 
were unable to migrate up the FN gradient and instead migrated away from the FN source, 
indicating that the pro-haptotactic effect of Mena on FN gradients is concentration-
dependent.
The role of integrins in FN haptotaxis, in particular the two major FN-binding integrins, 
α5β1 and αvβ3 integrins, remains poorly understood. Inhibition of α5β1 by the function 
blocking antibody P1D6, but not of αvβ3 by Cilengitide (25), blocked haptotaxis of 231-
Mena cells (FMI values decreased by over 90%; Fig1E), indicating that Mena-driven FN 
haptotaxis requires α5β1 signaling specifically. We tested whether Mena's ability to bind α5 
via its LERER domain was required for Mena to support haptotaxis (Fig1F). MDAMB231 
cell lines stably expressing GFP-tagged Mena in which the LERER domain was deleted to 
abrogate the interaction between Mena and α5 (231-MenaΔLERER)(15) showed no 
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apparent defects in protein localization (as judged by the GFP-tag), cell morphology, cell 
area or proliferation on plastic at steady state (FigS1B,C,F,G). 231-MenaΔLERER cells 
failed to haptotax in 3D to FN (FMIs reduced by over 90%; Fig1G), however, their 
migration velocity was similar to cells expressing intact Mena (Fig1H). Similar results were 
obtained in MVD7 fibroblasts on a 2D FN gradient (FigS1H,I). Previously, we found that, 
while the LERER domain was required for fibroblast spreading on FN, the F-actin binding 
site in Mena was dispensable(15)(Fig1F). Therefore, we investigated the role of the F-actin 
binding (FAB) site of Mena in FN-driven haptotaxis. 231-MenaΔFAB cells failed to 
haptotax in a FN gradient in a 3D collagen gel (Fig1G), while also displaying slight 
reductions in cell velocity (Fig1H). Overall, these data demonstrate that sensing changes in 
FN concentrations depends on α5β1 function, as well as the ability of Mena to bind α5 and 
to F-actin.
MenaINV drives haptotaxis in high FN concentrations in vitro and in vivo
We next investigated the role of the MenaINV isoform in driving haptotaxis. Cultured cells 
show little to no detectable MenaINV compared to spontaneous or xenograft mammary 
tumors(26). MDAMB231 and SUM159 cell lines stably expressing GFP-tagged MenaINV or 
MenaINVΔLERER constructs at levels similar to those generated for Mena (referred to as 
231- or 159-MenaINV or MenaINVΔLERER) were made (FigS1B,C). Surprisingly, unlike 
Mena, MenaINV enabled tumor cell haptotaxis through gradients of high FN concentrations, 
even up to 500 μg/ml (Fig2A), effects that were independent of velocity (FigS2A,B). In 
contrast, varied concentration gradients of either VN or LN failed to elicit significant 
haptotactic responses by 231-MenaINV cells, suggesting this response was specific to FN 
(FigS2D,E). Inhibition of α5β1, but not of αvβ3 blocked haptotaxis of 231-MenaINV cells 
(Fig2B,S2C). MenaINV also binds the cytoplasmic tail of α5 directly via its LERER domain; 
we found that 231-MenaINVΔLERER and 231-MenaINVΔFAB cells also failed to haptotax 
in 3D to FN (Fig2B). These findings were confirmed in 2D and 3D collagen gels using 
SUM-159 cells expressing the different GFP-tagged Mena isoforms (FigS2F-I). Overall, 
these data suggest that expression of MenaINV enables cells to haptotax at higher FN 
concentrations than Mena.
While upregulation of FN in aggressive tumors is thought to promote invasion and 
metastasis, whether FN gradients play a role in guiding tumor cell migration in vivo has not 
been established. Xenograft tumors were generated in in the mammary fat pad of 
immunocompromised mice using MDAMB231 and SUM159 cells. We assayed the ability 
of cells from the primary tumor to invade actively into microneedles loaded with collagen 
and increasing concentrations of FN(27). 231-Control tumor cells were not attracted to FN 
in vivo (Fig2C), while 231-Mena tumor cells exhibited a biphasic response with robust 
invasion by 231-Mena cells at intermediate FN concentrations, but little to no invasion into 
needles with either low or high FN concentrations (Fig2C). Interestingly, 231-MenaINV cells 
were still attracted into the needles containing the high concentrations of FN (Fig2C). While 
Mena can promote invasion in vivo in response to intermediate FN gradients, MenaINV 
allows tumor cells to migrate through substantially higher (2-fold greater) FN 
concentrations.
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To visualize FN-driven haptotactic responses inside tumors, we used a microscale 
implantable device that allows for in vivo release of molecules in gradients(28). Devices 
filled with Rhodamine-labeled FN were implanted near the edges of MDAMB231 or 
SUM159 orthotopic tumors to generate high concentration FN gradients (Fig2D). Using 
intravital imaging, cell motility and FMIs were quantified in response to gradients of FN or 
to fluorescently labeled dextran similar of size to FN as a control (FigS2J). Expression of 
MenaINV, but not Mena, in human MDAMB231 and SUM159 cells significantly increased 
the number of cells moving in the xenograft tumors an effect dependent on the interaction 
with α5β1 (FigS2L,M). In tumors implanted with FN-loaded devices, 231-MenaINV, but not 
231-Control or 231-Mena cells moved towards the FN gradient (Fig2E, representative 
images with cell tracks FigS2K and supplementary videos 1&2). In contrast, 231-
MenaΔLERER and MenaINVΔLERER cells did not. Similarly, cells in 159-MenaINV tumors 
migrated towards the FN, an effect that was absent in 159-Control or 159-MenaINVΔLERER 
tumor cells (Fig2F). Altogether, using the needle collection assay and intravital imaging, we 
show for the first time that haptotaxis towards FN occurring in vivo is driven by MenaINV 
and its interaction with α5.
Mena isoform expression correlates with FN and integrin α5 expression levels as well as 
outcome in human breast cancer patients
Previous work demonstrated that forced expression of MenaINV drives metastasis in 
xenograft tumor models(17) and that MenaINV mRNA levels, as detected by qPCR are 
relatively higher in cells that intravasate efficiently and in patients with high numbers of 
TMEM (a structure containing a tumor cell, macrophage and endothelial cell associated with 
the likelihood of metastasis in ER+/Her2− breast cancer patients) (29). However, the 
relationship between MenaINV mRNA or protein levels and patient outcome in human breast 
cancer patients has not been investigated. First, we analyzed the 1060 breast cancer patients 
in the TCGA cohort with RNAseq and clinical data available (30). Since the INV exon was 
not annotated when the RNAseq data were first analyzed, we accessed the raw sequence data 
and mapped reads in each sample to all Mena exons. Separating patients into quartiles 
according to Mena expression failed to reveal any significant correlations between Mena 
levels (judged by levels of constitutively-included exons) and overall survival in the entire 
TCGA breast cancer cohort (Fig S3A) or in the subset of patients with >10yr follow-up (Fig 
3A). However, patients with high levels (top 1/4) of MenaINV mRNA (as assessed by the 
abundance of INV exon sequence reads) exhibited significantly reduced survival compared 
to patients in each of the three lower quartiles of MenaINV expression (Figs 3B, S3B). 
Similar results were found in the node-negative patient subgroup (FigS3E). Furthermore, 
both Cox and logistic regression demonstrated that MenaINV was a substantially stronger 
predictor of poor outcome in patients with 10-year follow up than Mena alone (Figs 3C,D, 
S3C,D); models combining MenaINV and Mena expression levels failed to increase the 
predictive power beyond that of MenaINV. We next studied how MenaINV levels correlated 
with FN and α5 expression in this dataset. Overall Mena and MenaINV expression were both 
significantly correlated with FN, and to a lesser degree α5 (FigS3F). In particular, in patients 
with >10yr follow-up, we observed a highly significant correlation between Mena, MenaINV 
and FN or α5 in patients that succumbed to their disease, that was absent in surviving 
patients (FigS3G,H).
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Using a newly developed antibody specific for MenaINV(26), we then investigated the 
relationship between endogenous MenaINV, α5 and FN protein using immunostaining in the 
MMTV-PyMT spontaneous mouse model of breast cancer(31) and in a previously 
characterized tissue microarray (TMA) of 300 patients(32). Both Mena and MenaINV are 
expressed in PyMT tumors (Fig3E) and can be detected in cells that also express α5β1 
(Fig3F). MenaINV expression and distribution significantly correlated with that of FN in this 
model (Fig3G,H). We also found a significant correlation between FN and MenaINV levels 
in the TMA (Fig3I,J). Similarly, in patients represented by the TMA, higher MenaINV levels 
were significantly correlated with poor outcome (FigS3I). In addition, patients with 
recurrent disease, either local or at a distant site, had significantly higher levels of MenaINV 
(Fig3K). Logistic regression analysis indicated that MenaINV expression MenaINV was a 
significant predictor of recurrence (Coefficient of 0.377, p = 0.0186). An average 4.6-fold 
increase in MenaINV expression correlated with a 2-fold increase in the number of patients 
with recurrence (FigS3J,K). Further increases in MenaINV expression did not correlate with 
further increases in recurrence, suggesting that even small increases in MenaINV protein 
expression can affect recurrence. While mRNA levels of either MenaINV or FN alone did not 
correlate with time to disease recurrence, patients with high levels of both MenaINV and FN 
showed a statistically significant decrease in time to recurrence (Fig3L). Together, these data 
provide the first evidence that MenaINV RNA and protein levels correlate with tumor 
recurrence and survival and support a link between endogenous MenaINV, α5 and FN 
expression in breast cancer patients.
To evaluate the role of Mena/MenaINV-driven haptotaxis in metastasis, we quantified the 
number of spontaneous metastases in the lungs of mice with MDAMB231 and SUM159 
xenografts. Mice were sacrificed when primary tumor size reached 1cm in diameter. 
Interestingly, the initial growth rate of 231- and 159-MenaINVΔLERER tumors was slower 
than that of tumors generated from the other cell lines (FigS4A,B). While there were only 
minor changes in proliferation levels as detected using the marker Ki67, 231-
MenaINVΔLERER tumors had a 6-fold increase in levels of the apoptotic marker cleaved 
caspase-3 (FigS4D,E). This delay in tumor growth and increase in cell death could be 
rescued by co-injecting 231-MenaINVΔLERER cells with wild-type MDAMB231 cells 
expressing mCherry or by letting them grow for 12 weeks instead of 8 to reach 1cm in 
diameter (FigS4D,E). Expression of MenaINV significantly increased the metastatic index in 
the lungs 5-fold in both human cell lines at 8 weeks, compared to control 231s (Fig3M-O). 
Deletion of the LERER region in both Mena and MenaINV significantly decreased the lung 
metastatic index (Fig3N,O). Similar results were found in the poorly metastatic SUM159 
cell line (Fig S4E). Similarly, depletion of all Mena isoforms in MDAMB231 cells using 
shRNA also delayed tumor growth, as well as decreasing tumor cell motility and metastasis 
(FigS4G-M). These data support a model whereby Mena/MenaINV-driven α5-dependent 
haptotaxis plays a key role in promoting tumor metastasis.
Haptotaxis on FN gradients is dependent on signaling at focal complexes (FXs)
We next investigated the mechanism by which Mena isoforms drive haptotaxis at low and 
high FN concentrations. One way FN can support cell migration is by activating integrin-
mediated intracellular signaling pathways at FXs that promote cell motility(11). When 
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plated on 2D collagen and FN, both 231-Mena and 231-MenaINV cells showed increases in 
cell area and in the number of α5-positive adhesions relative to control cells, or to cells 
plated on collagen only, an effect dependent on α5 activity as well as the α5-binding LERER 
domain (Fig4A-E). While 231-MenaINV cells showed a 30% increase in both total and 
surface levels of α5, the steady state levels of αv, β1 and other integrins examined were 
unchanged (FigS5A-G). Furthermore, plating cells on FN also increased the levels of α5 
within Mena-positive adhesions (indicated by the GFP tag), with 231-MenaINV cells 
showing increased α5 levels relative 231-Mena cells (Fig4B,F). The FN-driven recruitment 
of α5 to Mena-positive adhesions was dependent on α5 activity as well as the LERER 
domain for both isoforms (Fig4F,G). 231-MenaINVΔLERER cells also had reduced number 
of Mena-positive adhesions (FigS5I).
Phosphorylation of several proteins at focal adhesions downstream of integrin activation, 
particularly focal adhesion kinase (FAK), is important for motility and tumorigenesis 
(11,33). Pharmacological inhibition of FAK inhibited Mena and MenaINV-driven haptotaxis 
on low FN gradients (Fig4H). Immunofluorescence of haptotaxing cells revealed that both 
231-Mena and MenaINV cells show increased number of pFAK397-positive adhesions 
(Fig4I,J). In 231-MenaINVΔLERER or 231-MenaINVΔFAB cells, the number of pFAK397-
positive adhesions in the cells was significantly lower than in 231-MenaINV cells (Fig4K). 
When cells were plated on high FN gradients, only 231-MenaINV cells haptotaxed (Fig S5J) 
and accordingly, these cells had a significant increase in the number of pFAK397-positive 
adhesions relative to 231-Mena or control cells (Fig4L). These data suggest that outside-in 
activation of integrins and Mena-dependent FX signaling by FN is important for haptotaxis 
of tumor cells.
The differences between focal complex composition, signaling and haptotaxis arising from 
expression of MenaINV vs. Mena prompted us to ask whether we could detect any relevant 
biochemical differences between the isoforms. Previously we demonstrated that Mena could 
be detected in complex with α5 by coimmunoprecipitiation (IP)(15). We performed α5 IPs 
to compare the amounts of Mena and MenaINV in complex with α5, and reproducibly 
detected an average 2.2 fold greater level of MenaINV compared to Mena by western blot of 
anti-α5 IPs (Fig4M,N). Thus inclusion of INV in Mena leads to significantly increased 
association with α5β1.
MenaINV-driven ECM remodeling is required for 3D haptotaxis
FN could also support haptotaxis through its role in providing structural support for cells, 
particularly in 3D and in the presence of collagen. FN fibrillogenesis exposes cryptic 
binding sites in FN normally hidden in the globular form(12) and fibrillar FN can bind 
collagen and regulate its deposition and organization(13). 231-Mena and MenaINV cells had 
increased number of protrusions in low FN gradients, while in high FN gradients, only 231-
MenaINV cells showed this phenotype (Fig S6A). Similarly, 231-MenaINV cells were more 
elongated than Mena or Control cells in the presence of a FN gradient in vivo, an effect 
dependent on the interaction with α5 (FigS6B,C). We also found that 231-MenaINV 
exhibited increased accumulation (20%) of FN (Fig5A,B) and collagen (Fig5A,C) at both 
low and high FN concentrations after 24 hrs, while neither 231-Mena nor 231-Control cells 
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exhibited any significant accumulation of the two ECM proteins. FN-triggered outside-in 
signaling was insufficient to support MenaINV-dependent haptotaxis in 3D gels, as 231-
MenaINV cells failed to haptotax on a gradient of FN7-11, a fragment of FN that activates 
signaling via RGD-binding integrins, but cannot form fibrils (12) (Fig5D). Inhibition of 
fibrillogenesis by addition of a 70kD FN fragment that contains the cryptic FN- and collagen 
binding sites in FN (34) blocked MenaINV-driven 3D haptotaxis (Fig5E). Therefore, the 
formation of FN fibrils is important for FN to evoke directional motility of tumor cells in 
3D. Addition of the 70kD FN fragment to spreading 231-MenaINV cells decreased the 
number of α5-positive adhesions as well as α5 recruitment to MenaINV-positive adhesions 
(FigS6D-G), suggesting that fibrillar FN may enhance assembly of α5β1-containing 
adhesions.
In 231-MenaINV cells, inhibition of α5β1 decreased accumulation of both FN and collagen, 
while inhibition of αvβ3 had little or no effect. 231- MenaINVΔLERER and 231-
MenaINVΔFAB cells had decreased FN and collagen (Fig5F,G) accumulation around the 
cells. Inhibition of protease activity with the broad-spectrum matrix metalloproteinase 
(MMP) inhibitor BB94 had no effect on ECM reorganization, but inhibition of acto-myosin 
contractility by the ROCK inhibitor Y-27632 did decrease collagen and FN accumulation 
around the cells (FigS6H,I). These results indicate that MenaINV-driven α5-dependent FN 
and collagen accumulation by the tumor cells themselves is important for haptotaxis.
MenaINV expression drives collagen reorganization in tumors
Given the role of MenaINV in driving ECM reorganization in vitro, the importance of FN for 
collagen fibrillogenesis(13), and recent published work showing that collagen organization 
can correlate with disease outcome(5), we next examined whether the changes in ECM 
accumulation observed short-term in vitro translated into significant changes in the structure 
and abundance of collagen in vivo. Using Second Harmonic Generation (SHG), we 
examined the structure and abundance of collagen in multiple tumors to investigate whether 
Mena and MenaINV were associated with changes in collagen abundance and organization in 
vivo. We examined the thickness of the collagen capsule surrounding the tumors. Intravital 
imaging of tumors revealed that deletion of the LERER in both 231-Mena and MenaINV 
tumors lead to significantly thicker, collagen capsules (FigS6J). Similarly, knockdown of 
Mena in 231 cells also led to an increase in collagen thickness (FigS6K). Histological 
analysis of tumor sections showed that tumors in MMTV-PyMT mice null for Mena, known 
to have significantly lower levels of metastasis(35), showed significantly increased collagen 
levels, compared to wild-type mice (Fig6A,B). Endogenous MenaINV levels in wild-type 
PyMT tumors were correlated with lower levels of collagen (Fig6C,D). In patients with high 
MenaINV expression, there was significantly lower collagen signal than in patients with low 
MenaINV expression (Fig6E,F). Together, these data suggest that highly invasive tumors 
arising from, or correlating with MenaINV expression were associated with thinner collagen 
capsules, while the poorly metastatic tumors arising from Mena deficient cells were 
associated with thicker collagen capsules.
While the amount of collagen deposition surrounding tumor an important factor in local 
invasion, changes in collagen shape and orientation have also been linked with invasiveness. 
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A lower density of collagen organized into straight fibers oriented perpendicularly to the 
edge of the tumor has been associated with poor outcome in a breast cancer cohort (5). 
Representative images of the collagen at the edge of the MDAMB231 and SUM159 
xenograft tumors show 231-Control and 231-Mena tumors had dense, curly collagen fibers, 
organized in all directions relative to the tumor edge (Fig6G,H, FigS6L). However, 231-
MenaINV tumors displayed a significantly increased frequency of fibers orientated 
perpendicular to the tumor edge (Fig6G,H). 231-MenaΔLERER and 231-MenaINVΔLERER 
tumors had collagen fibers parallel to the tumor edge (FigS6L,M). Indeed, these tumors 
contained abundant collagen fibers with very small angles relative to the tumor edge. Both 
phenotypes were also observed in tumors generated with SUM159 cells (Fig6G, S6N,O). 
Together, these results indicate that the initial MenaINV-dependent changes in ECM 
accumulation observed in our short-term in vitro assays can translate in vivo (over much 
longer time scales associated with tumor progression) into significant reductions in overall 
accumulation of encapsulating collagen accompanied by increased abundance of linear 
fibers oriented perpendicularly to the tumor margin.
Discussion
Our results lead us to propose a novel mechanism by which tumor cells sense, respond to, 
and reorganize the ECM to support metastasis (summarized in Fig 7). Integrin-dependent 
outside-in signaling at FXs, as well as inside-out ECM remodeling are necessary for 
directional migration towards FN. FN and α5 expression are upregulated in breast cancer 
tumors and high levels of tumor FN and α5 have been associated with poor outcome(7), 
though not, by themselves, in the datasets we analyzed. Given the heterogeneous levels of 
FN within both the primary tumor and metastatic niche, disseminating cells must be able to 
migrate effectively through areas of different FN concentrations, as well as to move from 
areas of low FN to areas of high FN and vice versa. In addition to simply being permissive 
for migration, we show that FN acts as a directional cue in vivo. Expression of Mena drives 
haptotaxis at low FN concentrations, while expression of MenaINV allows cells to migrate at 
high concentrations of FN similar to those present around blood vessels in tumors(9). 
Abrogation of the interaction between Mena/MenaINV and α5β1 abolished haptotaxis in 
vitro, while also significantly decreasing metastasis in two mouse xenograft breast cancer 
models. Together, these findings support the idea that FN can act as a potent guidance and 
motility cue for tumor cells during metastatic progression.
At a mechanistic level, inclusion of the INV sequence increases the association of Mena 
with α5 by 2.2 fold. We propose that increased association of MenaINV vs. Mena with α5 
likely underlies the isoform-specific differences in α5β1-mediated effects on haptotaxis and 
focal complexes. The INV sequence is inserted between the amino terminal EVH1 domain 
in Mena, which mediates interactions with several other molecules associated with integrin 
function, and the LERER domain, which binds directly to α5(15,36). It will be of great 
interest to determine exactly how the INV sequence modifies interactions with α5.
The ECM can also deliver signals to other types of receptors by providing binding sites for 
their ligands (37). While it is well established that proteoglycans directly bind growth 
factors, allowing the ECM to act as a reservoir for invasive signals (38), emerging evidence 
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suggests that ECM proteins contain domains that may allow them to activate receptor 
tyrosine kinases directly. FN-mediated activation of α5β1 can, for example, lead to HGF-
independent activation of Met to promote invasion in ovarian cancer cells (39). In addition, 
expression of mutant p53 protein, which is mutated in 50% of cancers (40), can drive 
invasion through enhanced RCP-dependent co-recycling of α5β1 with several receptor 
tyrosine kinases (RTKs), including EGFR and Met (25,41). Given that MenaINV expression 
sensitizes cells to EGF, enabling them to invade and migrate in response to low EGF 
concentrations (17,18,42), it will be interesting to investigate the potential role of crosstalk 
with RTK signaling in MenaINV-driven haptotaxis.
The importance of tumor-cell-driven FN fibrillogenesis and ECM remodeling in MenaINV-
driven haptotaxis is surprising. FN polymerization is required for deposition of collagen 
I(34) and antibody binding to the collagen-binding site on FN inhibits collagen 
fibrillogenesis(43). Here, we show for the first time that tumor-cell-mediated FN 
fibrillogenesis is required for haptotaxis, a process driven by expression of MenaINV. We 
also show the first evidence for tumor-cell-driven collagen reorganization in vivo, also 
driven by MenaINV and its interaction with α5β1. Together, these data suggest that tumor 
cells can pave their own way to blood vessels. While the mechanism by which FN and 
integrins drive collagen fibrillogenesis remains incompletely understood, our results indicate 
that MenaINV provides a link between integrin activation and the cytoskeleton to drive ECM 
organization by tumor cells. The MenaINV-driven reduction in collagen encapsulation and 
increase in linear fibrils radiating from the tumor periphery, in turn, further enhance 
metastatic phenotypes. Overall, our findings highlight the potential importance of bi-
directional integrin-mediated signaling in the tumor cell compartment in addition to the 
previously characterized contributions from stromal cells(4) in the regulation of ECM 
structure.
Our data also support a role for the relationship between MenaINV, α5 and FN in human 
breast cancer. Using an isoform-specific antibody and bioinformatic analysis of available 
TCGA data, we found that high expression levels of MenaINV and FN are associated with 
increased recurrence and poor outcome in two human breast cancer cohorts. Future studies 
on larger patient cohorts will be needed to help determine the utility of MenaINV as a 
diagnostic and prognostic marker, and whether it provides additional information when used 
in conjunction with other tumor markers. Altogether, our findings reinforce the importance 
of MenaINV in human breast cancer, and suggest that targeting the chemotactic and 
haptotatic pathways by which MenaINV promotes invasion could be useful therapeutically 
for metastatic breast cancer.
Materials and methods
Antibody reagents, growth factors and inhibitors
Antibodies: α5 (for IF: BD Biosciences, #555651, for IP: Millipore, AB1928 and for WB: 
Santa Cruz Biotechnology, sc-166681), αv (BD Biosciences, 611012), α6 (Abcam, 
ab10566), α2 (Abcam, ab133557), β1 (BD Biosciences, 610467), FAK (BD Biosciences, 
610087), pFAK Y397 (Invitrogen, 44-625G), Cleaved Caspase 3 (CST, 9661), Ki67 (CST, 
9027), FN (BD Biosciences), p53 (CST, clone 1C12), RCP (Sigma). See (26) for description 
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of MenaINV rabbit monoclonal antibody. Animals were immunized with a peptide 
containing the sequence encoded by the INV exon. Clones were screened for MenaINV 
specificity in Western blot assays and by immunostaining of FFPE tumor sections from wild 
type or Mena-null mice (FigS3) (26). Cilengitide (Selleck Chemicals), P1D6 α5 blocking 
antibody (DSHB), FAKi (Santa Cruz), 70kD fragment and its control peptide for blockade 
of fibrillogenesis (gift from Dr. Sottile, University of Rochester), FN 7-11, purified from a 
plasmid from ROH).
Cell culture
MDAMB231 cells were purchased directly from ATCC in June 2012, where cell lines are 
authenticated by short tandem repeat profiling. These cells not re-authenticated by our lab, 
and were cultured in DMEM with 10% FBS (Hyclone). SUM159 cells were obtained from 
Joan Brugge's lab at Harvard Medical School (January 2011) and were not re-authenticated 
in our lab. SUM159 cells were cultured according to the ATCC protocols. MVD7 fibroblasts 
cells were isolated from mice in our lab in October 1999 and cultured as previously 
described(15). These cell lines were authenticated in our lab and deletion of Mena was 
verified at the mRNA and protein level. Retroviral packaging, infection, and FACS were 
performed as previously described (15). Cell lines were engineered to express Mena 
isoforms stably at 10-15-fold higher levels than parental lines. MVD7 fibroblasts were 
isolated were maintained at 32°C, 5% CO2 in DME supplemented with l-Glutamine, 
penicillin and streptomycin, 15% fetal bovine serum, and 50U/ml interferon (I-4777; Sigma) 
(15). Stable Knockdown cell lines were generated using mir30-based shRNA sequence 
‘CAGAAGACAATCGCCCTTTAA’ for Mena expressing an mCherry tag.
Immunohistochemistry
Fixation, processing and staining of tissue sections from tumors was carried out as 
previously described (18). Tumors dissected from NOD/SCID mice were fixed in 10% 
buffered formalin and embedded in paraffin. Tissue sections (5μm thick) were deparaffinized 
followed by antigen retrieval using Citra Plus solution (Biogenex). After endogenous 
peroxidase inactivation, sections were incubated with primary antibodies overnight at 4°C 
and fluorescently labeled secondary antibodies at room temperature for 2 hrs. Sections were 
stained using the following antibodies: anti-Mena (1:500), anti-Ki67 (BD Biosciences), 
cleaved Caspase-3 (BD Biosciences). Fluorochromes on secondary antibodies included 
AlexaFluor 594, AlexaFluor488 and AlexaFluor 647 (Jackson Immunoresearch). Sections 
were mounted in Fluoromount mounting media and imaged at room temperature. Z series of 
images were taken on an Applied precision DeltaVision microscope using Softworx 
acquisition, an Olympus 40x 1.3 NA plan apo objective and a Photometrics CoolSNAP HQ 
camera. Images were deconvolved using Deltavision Softworx software and objective 
specific point spread function. At least 4 images were captured for each tumor, with at least 
3 tumors per tumor group.
TMA
Details of the patient cohort and associated data used to generate the TMA are published 
(32). The TMA was stained by immunofluorescence and imaged with a Vectra automated 
slide scanner and a 20X objective. The field of view with this objective covers 90% of the 
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core spot. Each patient had three cores on the TMA. All were imaged, but some had to 
removed due to lack of tissue or folded tissue. Fluorescence intensity in the tumor 
compartment was analyzed using Inform software. MenaINV and FN intensity metrics are in 
arbitrary units.
Haptotaxis assays
Microfluidic devices were prepared as described (19). For haptotaxis on a 2D matrix, after 
bonding PDMS devices to Mattek dishes, the chamber was coated with 0.1mg/ml Collagen I 
for 1hr at 37°C and then 250μg/ml fluorescently-labeled FN was flowed through the source 
channel for 1hr. Cells were then plated in the device in full serum media and left to attach 
for 1hr before imaging. For haptotaxis in a 3D matrix, cells were resuspended in 1mg/ml 
collagen I (BD Biosciences) with 10X DMEM and 1N NaOH and 3nM EGF in full serum 
media, plated in the cell culture chamber, and left to settle for 8hrs at 37°C. Fluorescently-
labeled FN was then flowed through the source channel for 1hr before imaging. For all 
haptotaxis experiments, the FN concentration represents the concentration at the top of the 
gradient. Unless mentioned, FN concentration at the top of the gradient is 125μg/ml. Cells 
were imaged overnight in the haptotaxis device, with images being acquired every 10min for 
16hr in an environmentally controlled microscope (TE2000, Nikon) with a 20X objective 
and a Photometrics Coolsnap HQ camera. Individual cells were manually tracked using 
ImageJ software Manual Tracking plug-in. The tracks obtained were analyzed using the 
Chemotaxis Tool ImageJ plugin (from Ibidi). This analysis tool was used to extract the FMI 
(Fig 1A) along with the velocity of migration and the persistence of migration using the D/T 
ratio (net path length/total path length) (20,44).
Tumor formation and metastasis assay
All animal experiments were approved by the MIT Division of Comparative Medicine. For 
xenograft experiments, MDAMB231 or SUM159 cells (2 million per mouse in PBS and 
20% collagen I) expressing different Mena isoforms were injected into the 4th right 
mammary fat pad of six week-old female NOD-SCID mice (Taconic). Tumor size was 
measured weekly with calipers. 8 or 12 weeks post-surgery, once tumors had reached 1cm in 
diameter, mice were used for intravital imaging, and then sacrificed and their tumors and 
lungs were fixed in 4% formalin overnight. Metastatic index was calculated by counting the 
number of metastases in each lobe relative to the weight of the tumor. Each tumor group 
contained 4-6 mice. PyMT-MMTV mice were obtained from Jackson, mice were left to 
growth for 15-20 weeks, when they had developed tumors of about 1.5 cm in diameter. 
Histological analysis of H&Es from these tumors confirmed these tumors were advanced 
carcinoma.
In vivo invasion assay
The in vivo invasion assay was performed in at least 4 mice per condition as previously 
described (45). Briefly, needles were held in place by a micromanipulator around a single 
mammary tumor of an anesthetized mouse. Needles contained a mixture of 0.5mg/ml 
Collagen I, EDTA with L-15 media or increasing amounts with FN. After four hours, the 
contents of the needles were extruded. Cells were stained with DAPI and counted.
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Intravital Imaging and in vivo haptotaxis
Intravital multiphoton imaging was performed as described previously (23) using a 25x 
1.05NA water immersion objective with correction lens. For in vivo haptotaxis, a microscale 
device filled with multiple reservoirs(28) with powdered rhodamine-FN or dextran was 
prepared. After exposing the tumor, the device was implanted into the tumor edge. Hour-
long time-lapse movies were analyzed for frequency of motility and tracking, and to 
measure and quantify cell characteristics in 3D and over time using NIH ImageJ. Cells that 
were either protruding or moving were counted as motile. For each movie, the FMI was 
calculated, with the angle for each track made relative to the direction of FN gradient for 
each frame. Data is pooled from 2-4 mice per tumor group, with 4-10 fields imaged per 
mouse, with a total of at least 70 cells per tumor type tracked. Collagen signal was 
visualized by second harmonic generation and images were analyzed using CT-Fire software 
(46) to calculate collagen fiber orientation, width and length. Data were pooled from 2-4 
mice per tumor group, with 4-10 fields imaged per mouse.
Western Blot/Immunoprecipitation
For the α5 immunoprecipitation, 231-Mena and 231-MenaINV were lysed with CSK buffer 
(10 mM PIPES – pH 6.8, 50 mM NaCl, 150 mM sucrose, 3 mM MgCl2, 1 mM MnCl2, 0.5% 
Triton X-10, protease and phosphatase inhibitors) and passed through a 23-gauge needle. 
Lysates were precleared with protein A beads for 1.5 h, incubated with the integrin α5 
antibody (1928; Millipore) for 2.5 h at 4°C, and then captured with 3% BSA-blocked protein 
A beads for 2 h. Beads were washed three times in CSK lysis buffer, and proteins were 
eluted in 2x sample buffer. Standard procedures were used for protein electrophoresis, 
western blotting, and immunoprecipitation. MDAMB231 expressing different Mena 
isoforms were lysed in 25mM Tris, 150mM NaCl, 10% glycerol, 1% NP 40 and 0.5M 
EDTA with a protease Mini-complete protease inhibitors (Roche) and a phosphatase 
inhibitor cocktail (PhosSTOP, Roche) at 4°C. Protein lysates were separated by SDS-PAGE, 
transferred to a nitrocellulose membrane, blocked with Odyssey Blocking Buffer (LiCor), 
incubated in primary antibody overnight at 4°C. Proteins were detected using Licor 
secondary antibodies. Protein level intensity was measured with Image J and data were 
pooled from at least 3 different experiments.
FACs
MDAMB231 cells expressing the different isoforms were trypsinized, resuspended in media, 
and then incubated with a primary antibody in PBS and 5% media for 30mins on ice. Next, 
the cells were incubated with a species appropriate Alexa647-tagged secondary antibody and 
then resuspended in PBS with 10μg/ml propidium iodide. Samples were then analyzed on a 
FACS-Calibur machine (BD Biosciences). Data is pooled from at least 3 separate 
experiments, with 10 000 cells analyzed per experiment.
Immunofluorescence
Cells were plated in a haptotaxis device on a 125 μg/ml 2D FN gradient for 3 hr or on 
collagen-coated glass-bottomed dishes (MatTek) in serum-free media for 30 min at 37°C. 
Cells were then fixed for 20 min in 4% paraformaldehyde in PHEM buffer, then 
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permeabilized with 0.2% TritonX-100, blocked with 10% BSA and incubated with primary 
antibodies overnight at 37°C. Z series of images were taken on an Applied Precision 
DeltaVision microscope using Softworx acquisition, an Olympus 40x 1.3 NA plan apo 
objective and a Photometrics CoolSNAP HQ camera. Images were deconvolved using 
Deltavision Softworx software and objective specific point spread function. Images were 
analyzed with ImageJ. Images are pooled from at least 3 independent experiments, at least 
10 cells per experiment.
MenaINV TCGA data retrieval
RNAseq data in fastq format were obtained from TCGA. For each sample, ENAH (Mena)-
derived reads were extracted from the full dataset by aligning to a target database that 
contained collection of all possible ENAH isoforms using BWA version 0.7.10. Properly 
paired ENAH reads were then extracted with Samtools version 0.1.19. ENAH isoforms were 
then quantified by aligning to hg19 using tophat2 version 2.0.12 guided with an edited GTF 
file derived from the USCS known genes annotation that contained all ENAH variants of 
interest. Bedtools version 2.20.1 and a custom python script were then used to count reads 
that overlap with each ENAH exon. The resulting counts per exon were then normalized for 
RNA loading by calculating a counts per million reads per Kb of mRNA using a sum of 
exon-level counts in the publicly available and preprocessed TCGA data as the total aligned 
counts denominator.
Survival/recurrence data analysis
The relationship between Mena/MenaINV expression levels (from mRNA TCGA or protein 
TMA) and survival (time to death) or metastasis (time to recurrence) was assessed by Log 
rank Mantel-Cox test. In each samples, patients were binned into quartiles according Mena 
or MenaINV expression (Q1 being the highest level of expression and Q4 being the lowest). 
The hazard ratio for each quartile (with 95% confidence interval values) was calculated. The 
p value generated by this log rank test evaluates whether the difference in the curves is 
significantly different. We also performed the Log rank test for trend to further assess the 
differences between the curves representing patients with varying levels of Mena isoform 
expression.
The hazard effects of MenaINV and Mena upon the time to death were investigated by Cox 
regression using R 2.15.3 basing on TCGA BRCA data. In order to make comparison across 
variables, we first standardized Mena and MenaINV RPKM values to mean zero and standard 
deviation one. Cox regressions were then carried out basing on the standardized MenaINV 
values or the standardized Mena RPKM values as the only independent variable to predict 
the effects upon the time of death of the BRCA patients in TCGA study. The association 
between MenaINV/Mena expression level and survival status of TCGA BRCA subjects was 
evaluated by logistic regression using R 2.15.3. In order to compare coefficients across tests, 
we first standardized INV and Mena values to be mean zero and standard deviation one. 
Logistic regressions were conducted by choosing survival status as dependent variable (1 as 
death, and 0 as alive). The only independent variable fitted in the model was INV, or Mena 
respectively. P values and coefficients corresponding to the independent variables were used 
to judge the significance of the association as well as the strength of the association.
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Statement of significance
Here, we provide new insight into how tumor cell: ECM interactions generate signals and 
structures that promote directed tumor cell migration, a critical component of metastasis. 
Our results identify a tumor-cell-intrinsic mechanism driven by the actin regulatory 
protein Mena, that promotes ECM remodeling and haptotaxis along FN gradients.
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Figure 1. Mena-driven haptotaxis in vitro on FN gradients in 2D and 3D is dependent upon its 
direct interaction with α5 integrin and F-actin
A) Schematic diagram of a microfluidic device used for 2D or 3D haptotaxis, representative 
image of a FN gradient in a collagen gel, and a diagram describing the FMI used to quantify 
haptotaxis. B) Expression of Mena, but not VASP or EVL, in MVD7 fibroblasts drives 
haptotaxis on a 2D FN gradient (125μg/ml at top of gradient), as measured by the FMI. C) 
231-Mena cells haptotax when plated on a 2D FN gradient (125μg/ml at top of gradient), but 
not on a LN or VN gradient, as measured by the FMI. D) MDAMB231 cells 231-Mena cells 
plated in a 3D collagen gel and subjected to increasing concentrations of FN at the top of the 
gradient. E) Inhibition of α5β1 with P1D6 (0.5μg/ml) blocked Mena-driven haptotaxis in 3D 
collagen gels, as measured by FMI, while inhibition of αvβ3 with Cilengitide (1μM) had no 
effect. F) Diagram of structure of Mena and its domains, including the LERER domain and 
the F-Actin binding domain (FAB). Deletion of the LERER domain abrogates the interaction 
of Mena/MenaINV with α5. G) 231-MenaΔLERER and MenaΔFAB cells did not haptotax in 
3D collagen gels and this effect was independent of an effect on velocity (μm/min) (H). For 
each experiment, n=3 experiments, at least 80 cells tracked per condition. Results show 
mean ± SEM, significance by one way ANOVA, *p<0.5, **p<0.01, ***p<0.005. See FigS1.
Oudin et al. Page 20
Cancer Discov. Author manuscript; available in PMC 2016 November 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 2. MenaINV-drives haptotaxis at high FN concentrations in vivo and in vitro
A) 231-MenaINV cells plated in a 3D collagen gel and subjected to increasing concentrations 
of FN at the top of the gradient B) Inhibition of α5 with P1D6 (0.5μg/ml) blocked MenaINV-
driven 3D haptotaxis, as measured by FMI, while inhibition of αvβ3 with Cilengitide had no 
effect. 231-MenaINVΔLERER or 231-MenaINVΔFAB did not haptotax in 3D. (n=3 
experiments, ≥150 cells tracked per condition). C) In vivo invasion assay into needles 
inserted in tumors generated in NOD/SCID mice with MDAMB231 cells expressing 
Control-GFP, Mena or MenaINV. Needles contained 0.5mg/ml collagen and increasing 
amounts of FN (n=4 mice per condition). Results show mean ± SEM. Stars above columns 
represent significance relative to collagen only by one-way ANOVA. D) Representative 
image of a FN gradient (Rhodamine-labeled FN, shown in red) on collagen fibers (shown in 
white) generated using a microscale implantable device implanted into the tumor (tumor 
cells labeled with GFP shown in green) and visualized by intravital imaging. Scale bar is 
100μm. FMI of E) MDAMB231 and F) SUM159 tumor cells expressing different Mena 
isoforms in the absence of a device, or in the presence of a device releasing fluorescently 
labeled FN or similarly sized Dextran (data pooled ≥8 movies from ≥2 mice per condition). 
Results show mean ± SEM, significance by one way ANOVA, *p<0.5, **p<0.01, 
***p<0.005. See FigS2.
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Figure 3. MenaINV is associated with poor outcome in human tumors and requires its interaction 
with α5 integrin for metastasis
Kaplan-Meier curves for survival of breast cancer patients binned by quartiles of Mena (A) 
or MenaINV (B) mRNA levels, as indicated (Q1 had the highest expression, Q4 the lowest). 
Data are from 128 breast cancer cases with >10 years of follow up BRCA TCGA dataset 
(data from entire 1060 patient cohort in Figs S3A-D). Significance calculated by log-rank 
Mantel-Cox test, hazard ratio calculated by logrank test, pTrend calculated by log-rank test 
for Trend (see methods). C) COX regression carried out to assess the relationship between 
Mena or MenaINV and time to death in breast cancer patients (patients with 10-year follow-
up). D) Logistic regression carried out to assess the relationship between Mena or MenaINV 
and survival in breast cancer patients (patients with 10-year follow-up). E) Representative 
images of PyMT-MMTV tumors stained for Mena (red) and MenaINV (green) Scale bar = 
20μm. F) Representative images of PyMT-MMTV stained for MenaINV (green) and integrin 
α5 (red) Same scale as E. G) Representative image from a wild-type PyMT tumor FN (red), 
MenaINV (green) and nuclei (DAPI staining) Scale bar = 100μm. H) Correlation between 
MenaINV and collagen FN intensity. Data from over 50 fields from 4 PyMT mice, each dot 
represents an individual field. I) Representative image of tumor spot from a tissue 
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microarray with high levels of MenaINV (green) and FN (red). J) Correlation between FN 
and MenaINV staining in the entire patient cohort. K) MenaINV expression in 300 breast 
cancer patients comparing patients with or without recurrence, data shows mean +/− SEM. 
L) Table showing the median recurrence-free time in months and corresponding p-value in 
patients with high vs. low MenaINV, high vs., low FN or high vs. low MenaINV+FN. 
Significance calculated by log-rank Mantel-Cox test. M) Representative fluorescence images 
of GFP-positive metastasis in lungs of mice with 231-Control, Mena or MenaINV tumors. 
Scale bar = 50μm. N) H&E images of FFPE sections cut from the lungs of mice bearing 
MDAMB231 tumors expressing different Mena isoforms. Scale bar is 100μm. O) Lung 
metastatic index of NOD-SCID mice bearing tumors grown from MDAMB231 cells 
expressing different GFP-tagged Mena isoforms and measuring at least 1 cm in diameter 
(n≥4 mice per cell line). Data show mean ± SEM, significance by one way ANOVA, *p<0.5, 
**p<0.01, ***p<0.005. See FigS3 and S4.
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Figure 4. MenaINV drives haptotaxis via increased FX signaling
A) Representative images of 231-Control, Mena and MenaINV cells plated on FN and 
collagen, stained with antibodies to α5, and GFP (to visualize tagged GFP-Mena or GFP- 
MenaINV) and with phalloidin to visualize F-actin. Scale bar = 5μm. B) Magnification of 
inset shown in (A). Scale bar = 1μm. C) Quantification of cell area (in μm2) of MDAMB231 
cells expressing different isoforms when plated on collagen (0.1mg/ml) + FN (50μg/ml). D) 
Number of α5-positive adhesions relative to cell area for 231-Mena and 231-MenaINV cells 
for cells plated on collagen only, collagen (0.1mg/ml) + FN (50μg/ml), and in the presence 
of P1D6, α5-function blocking antibody. E) Number of α5-positive adhesions relative to cell 
area for cells plated on collagen + FN. F) Intensity of α5 signal in Mena-positive adhesions 
(as counted by GFP positivity) for 231-Mena and 231-MenaINV cells plated on collagen 
only, collagen (0.1mg/ml) + FN (50μg/ml), and in the presence of P1D6, α5-function 
blocking antibody. G) Intensity of α5 signal in Mena-positive adhesions (as counted by GFP 
positivity) in cells plated on a low 2D 125 μg/ml FN gradient. H) Inhibition of FAK (0.5μM) 
decreased MenaINV-driven 2D haptotaxis on a low 2D 125 μg/ml FN gradient. Data from ≥3 
experiments, with ≥80 cells tracked per condition. I) Representative images of 231-Control, 
Mena and MenaINV, 231-MenaΔLERER and MenaΔFAB cells plated on a low 2D 125 
μg/ml FN gradient, stained with pFAK397 (red) and Phalloidin to visualized F-actin (blue). 
Scale bar = 5μm. J) Quantification of pFAK Y397-positive adhesions in 231-Control, Mena 
or MenaINV, while plated on a 2D low 125 μg/ml FN gradient K) 231-MenaINVΔLERER or 
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231-MenaINVΔFAB cells had decreased number of pFAK Y397-positive adhesions on a 2D 
low 125 μg/ml FN gradient. L) Quantification of pFAK Y397-positive adhesions in 231-
Control, Mena or MenaINV, while plated on a 2D high 500 μg/ml FN gradient Data pooled 
from 3 experiments, with at least 30 cells analyzed per condition. M) Representative image 
of a WB for α5-immunoprecipitation from 231-Mena and 231-MenaINV lysates, probed for 
Mena, α5 and Tubulin. N) Quantification of fold increase in Mena pulled down in α5-IP, 
n=4. For all staining experiments, data pooled from at least 3 experiments, with at least 10 
cells analyzed per experiments. Results show mean ± SEM, significance by one way 
ANOVA, *p<0.5, **p<0.01, ***p<0.005. Stars above data set represent significance relative 
to control. See FigS5.
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Figure 5. MenaINV-dependent directional motility requires ECM reorganizationin vitro
A) Representative images of MDAMB231 cells (outlined in white) and 231-MenaINV cells 
(green) in a 3D 125μg/ml FN gradient (red) in a collagen gel (blue) in merged image; middle 
and right panels show grayscale images of FN and Collagen alone, respectively. Scale bar is 
25μm. 231-MenaINV showed increased accumulation and reorganization of B) FN and C) 
Collagen, in both low 125μg/ml and high 500μg/ml 3D FN gradients. D) A gradient of 
recombinant 7-11 domains of FN failed to induce 3D haptotaxis of 231-MenaINV cells, as 
measured by the FMI E) Inhibition of FN fibrillogenesis by inclusion of a 70kD fragment 
ablated MenaINV–dependent haptotaxis in 3D FN gradients (n=3 experiments, ≥80 cells 
tracked per condition). Deletion of the FAB and LERER regions in MenaINV, and inhibition 
of α5β1 with P1D6, but not Cilengitide, reduced collagen (F) and collagen (G) accumulation 
at low FN concentrations. Data from ≥3 experiments, with ≥30 cells analyzed per condition. 
Results show mean ± SEM, significance by one way ANOVA, *p<0.5, **p<0.01, 
***p<0.005. See FigS6.
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Figure 6. MenaINV drives collagen reorganization in tumors
A) Representative image from a wild type and Mena −/− PyMT tumor showing collagen as 
imaged by SHG (gray) and nuclei (DAPI staining). Scale bar = 100μm. B) Quantification of 
collagen signal as measured by SHG signal in wild type and Mena −/− PyMT tumors. Data 
from over 30 fields from 4 mice for wild-type mice and 2 mice for Mena −/−, each dot 
represents an individual field. C) Representative image from a wild-type PyMT tumor 
showing collagen as imaged by SHG (gray) and MenaINV (green). Scale bar = 100μm. D) 
Correlation between MenaINV and collagen intensity. Data from over 50 fields from 4 mice, 
each dot represents an individual field. E) Representative images showing collagen by SHG 
from a breast cancer patient samples with high or low MenaINV. F) Collagen intensity in 30 
patients with high or low MenaINV expression. G) Representative images of collagen 
organization (gray) of 231-Control, Mena and MenaINV xenograft tumors taken by intravital 
imaging. Scale bar is 100μm. H) Representative diagram of angle used to measure the 
orientation of individual collagen fibers relative to the edge of the tumors. Plotted 
distributions of collagen fiber orientation relative to tumors edge comparing Control, Mena 
and MenaINV expressing H1) MDAMB231 and H2) SUM159 cells. Data pooled from ≥15 
images from ≥4 mice per condition. Results show mean ± SEM, significance by t-test, 
*p<0.5, **p<0.01, ***p<0.005. See Fig S6
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Figure 7. Summary diagram
FN levels are high around blood vessels and at invasive edges in tumors. Expression of 
Mena in tumor cells allows cells to haptotax on low gradients of FN, via its weak association 
with α5 and increased FX signaling. Expression of MenaINV allows cells to haptotax on both 
low and high FN gradients via increased association with α5, leading to increased FX 
number and FAK signaling at FXs, as well as through ECM reorganization.
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